Study of Helicobacter pylori infection in dialysis patients

Multicenter epidemiological study of Helicobacter pylori infection in dialysis patients - Multicenter epidemiological study of Helicobacter pylori infection in dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043933

Enrollment

240

Registered

2021-04-20

Start date

2021-03-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis Helicobacter pylori infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients on chronic hemodialysis with anti-H.pylori antibody or rapid urease test or H.pylori speculum examination will be the dialysis group. Patients with anti-H.pylori antibody or rapid urease test or H.pylori speculum examination and eGFR of 60 mL/min/1.73 m2 or higher in the human health checkup will be defined as the control group.

Exclusion criteria

Exclusion criteria: Patients who have received previous H. pylori eradication treatment or whose eradication history is unknown.Patients who have undergone rapid urease testing and are taking PPIs or mucosal protectants.

Design outcomes

Primary

Measure	Time frame
Prevalence of H.pylori infection between patients with hemodialysis and normal renal function	—

Secondary

Measure	Time frame
Relationship between prevalence of H.pylori infection and duration of hemodialysis Prevalence of H.pylori infection in hemodialysis by age	—

Countries

Japan

Contacts

Public ContactNoriko Takahashi

Gifu University Department of General Internal Medicine

sannomiya-gif@umin.ac.jp058-230-6632

Outcome results